August 7, 2015

USF’s targets Tampa Bay’s top students, closes gap with UF
Tampa Bay Times – Aug. 7
The school also partners with local hospitals, including Moffitt Cancer Center, James A. Haley Veterans' Hospital and Tampa General, among others. The partnership creates convenient opportunities for Tampa-based medical school students who need to complete internships or residencies.

Robert Ingram appointed to BioCryst’s Board of Directors
PressWire – Aug. 6
Bob is a member of the boards for the James B. Hunt Jr. Institute for Educational Leadership and Policy, H. Lee Moffitt Cancer Center, CEO Roundtable on Cancer, Research Triangle Institute and Chairman, GlaxoSmithKline Foundation. He serves as Chairman of the Research Triangle Foundation of North Carolina and is on the Advisory Board, Leonard D. Schaeffer Center for Health Policy & Economics, University of Southern California.

Hep to the groove: Heptares, Astrazeneca pair up in $510M immuno-oncology deal
Bioworld – Aug. 5
In cancer, the class is less developed, and most programs are still operating under the radar. Palobiofarma SL, of Barcelona, Spain, has submitted an investigational new drug application for PBF-509, with a view to conducting a phase I trial in patients with advanced non-small-cell lung cancer, in collaboration with the H. Lee Moffitt Cancer Center, of Tampa, Fla.

Amy Scherzer's Diary: Wrapup of the Tampa social scene
Tampa Bay Times – Aug. 4
So what if the dry martinis got a little wet? Pouring rain didn't deter the outpouring of support from 1,000-plus partiers at Martinis for Moffitt.

Institutional 'Diversity' May Impact Patient Participation in PGx Research, Study Finds
GenomeWeb – Aug. 4
"Our study demonstrates that race alone does not explain participation" in correlative studies, researchers led by Moffitt Cancer Center's Howard McLeod wrote in the paper. "Factors at the institutional level also need to be considered."

Decipher Predicts Metastasis and Identifies Biomarkers Predictive of Aggressive Disease in African American Men
Pharmacy Choice – Aug. 4
"African American men have historically experienced a higher incidence of mortality from prostate cancer than men of other races and ethnicities, and clinicians have long sought a better understanding of what drives this more aggressive disease," said Kosj Yamoah, M.D., Ph.D., Assistant Professor in Radiation Oncology, Genitourinary Program Moffitt Cancer Center & Research Institute. 

Polk County People in Medicine
The Ledger – Aug. 4
Mark Cook is LRH's new manager of business and finance systems, He led the business and financial systems team at Moffitt Cancer Center for the past eight years. Cook holds a bachelor's degree in management from Florida Southern College. He has served as vice president of the Florida Lawson Users Group.

Trigemina Appoints Dr. Shashi Kori to the Position of Chief Medical Officer
Yahoo Finance – Aug. 4
Prior to GSK, Dr. Kori spent 24 years in academic medicine at major U.S. medical centers and universities (Sloan Kettering Cancer Center, Case Western Reserve University, Moffitt Cancer Center and Duke University) providing him with extensive experience in clinical patient care.

Short-Course Radiotherapy: Short on Results for Prostate Cancer
Clinical Oncology News – Aug. 4
Commenting on the role of SBRT in prostate cancer, Richard Wilder, MD, a radiation oncologist at Moffitt Cancer Center, in Tampa, Fla., said, “There are two schools of thought on prostate SBRT. One argues that there should be a minimum of 10 years of published follow-up before a prostate cancer treatment can be considered standard of care … that both prospective and randomized studies are indicated to confirm the encouraging results with prostate SBRT at five to six years.

Medical Device Investments to become center of excellence for the commercialization of innovative medical technologies
Today’s Medical Developments - Aug. 4
Since incorporating in September, MDI has obtained the licensing rights to six devices invented at Moffitt Cancer Center in Tampa, including five by anesthesiologist Dr. Tariq Chaudhry, and two interventional cardiology catheters by cardiologist Dr. Hitinder Gurm at the University of Michigan.

Westshore sees more pedestrians, bicyclists in its future
83 Degrees – Aug. 4
The growth reflects the synergy created by proximity to Tampa International Airport, International Plaza, Moffitt Cancer Center’s Outpatient Facility, Raymond James Stadium, Westshore Mall, and dozens of hotels, restaurants and small shops.  

The parties may be over at Tampa's popular A La Carte Pavilion
Tampa Bay Times – Aug. 3
Moffitt Cancer Center has moved its annual Magnolia Ball, an event that raised $3.2 million this year, to the Tampa Marriott Waterside Hotel & Marina in April 2016. St. Joseph's Hospital Foundation bumped its Heroes Ball to the Grand Hyatt Tampa Bay in May 2016.

To lower LGBTQ people's cancer risk, educate patients – and doctors
The Guardian – Aug. 3
A study we published this month with colleagues from the H Lee Moffitt Cancer Center & Research Institute in Tampa and the University of Pennsylvania shows that this knowledge gap in those communities can be traced to the fact that LGBTQ people may lack health insurance or be uncomfortable sharing their sexual orientation or gender identity with their doctors. And even if doctors are aware, they lack comprehensive statistics on risk disparities for those populations.

Race and Institutional Support May Play a Role in Pharmacogenomic Trial Participation
ASCO Post – Aug. 3
Moffitt Cancer Center researchers published a study by Dressler et al in the Journal of the National Cancer Institute analyzing the participation rate of patients in pharmacogenomic trials.

Scene & Heard
Tampa Tribune – Aug. 2
About 1,200 guests enjoyed food, drinks and music at the 10th annual Martinis for Moffitt, benefiting the Advanced Prostate Cancer Collaboration at the Moffitt Cancer Center. The July 25 event at the Straz Center, hosted by Bay Area Advisors, featured music from Ka-Nection from New Orleans and a dinner menu with a New Orleans flair.

Amid FDA talks, e-cigarette industry braces for change
Tampa Bay Times – Aug. 2
"Public health researchers are really playing catch-up with the explosion of e-cigarettes onto the marketplace," said Thomas Brandon, director of the Tobacco Research and Intervention Program at Tampa's Moffitt Cancer Center, which recently received a $3.6 million grant from the National Institutes of Health to study e-cigarette use.

Cuba’s medical breakthroughs have caught U.S. attention
Tampa Tribune – Aug. 2
The H. Lee Moffitt Cancer Center & Research Institute in Tampa is one American institution that has expressed interest in the Cuban drug CimaVax, recently sending representatives to the island nation. Moffitt Vice President David de La Parte had little to say about the prospects of working with the institute. “Similar to Moffitt, the cancer hospital is focused on patient care, research and education,” de La ­Parte said in an email. “That resulted in a discussion about potential opportunities down the road in the areas of training, education and collaboration. We look forward to continuing our discussions.”

Tampa: Moffitt Researchers Develop First Genetic Test to Predict Tumor Sensitivity to Radiation Therapy
Outbreak News Today – Aug. 2
Moffitt Cancer Center researchers have contributed to these advances by developing the first test that analyzes the sensitivity of tumors to radiation therapy. They discovered that colon cancer metastases have varying sensitivity to radiation therapy based on their anatomic location.

US FDA clears KaloBios' NDA for KB003 to treat patients with chronic myelomonocytic leukaemia – Aug. 1
"I am very excited to be able to explore KB003, an anti-GM-CSF agent, as a potential therapeutic for CMML patients given the significant unmet medical need these patients face," said Dr. Eric Padron of the department of hematologic malignancies at H. Lee Moffitt Cancer Center and Research Institute in Tampa, Florida. 

For My Dad, One of the Best Men I Know – July 31
Dr. Goldman provided some of the earliest collaborations with Tampa General Hospital, helping lay the foundation for TGH becoming USF’s primary teaching hospital. He also was the founding director of the Thoracic Oncology and Lung Cancer Center at Moffitt Cancer Center.

Biomarkers in Hematological Malignancies: A Review of Molecular Testing in Hematopathology
Cancer Therapy Advisor – July 31
In this review, Mohammad Hussaini, MD, from the Department of Hematopathology and Laboratory Medicine at the Moffitt Cancer Center and Research Institute in Tampa, Florida, assessed current practices and trends for molecular testing in hematopathology by disease type, including chronic myelogenous leukemia, myelodysplastic syndrome, acute myeloid leukemia, and lymphoblastic leukemia/lymphoma.

Genetic Test Predicts Colon Tumor Sensitivity to Radiation Therapy
ASCO Post - July 31
Moffitt Cancer Center researchers have contributed to these advances by developing the first test that analyzes the sensitivity of tumors to radiation therapy. 


Please note we cannot guarantee the accuracy or availability of links. The stories belong to the respective publishers, and links may expire. Some news sites require you to register and select a password in order to retrieve articles, but most usually do not charge a fee to retrieve these news stories.